Holen Sie sich die Stockscreener-App
24.79
0.80%
-0.191
Schlusskurs vom Vortag:
$24.98
Offen:
$25.255
24-Stunden-Volumen:
309.51K
Relative Volume:
0.56
Marktkapitalisierung:
$727.75M
Einnahmen:
$17.16M
Nettoeinkommen (Verlust:
$-163.62M
KGV:
-4.0771
EPS:
-6.08
Netto-Cashflow:
$-121.61M
1W Leistung:
-8.19%
1M Leistung:
+11.62%
6M Leistung:
+38.20%
1J Leistung:
-28.87%
1-Tages-Spanne:
$24.39
$25.25
1-Wochen-Bereich:
$23.61
$27.47
52-Wochen-Spanne:
$12.21
$41.31
Anaptysbio Inc Stock (ANAB) Company Profile
Firmenname
Anaptysbio Inc
Sektor
Branche
Telefon
858-362-6295
Adresse
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Vergleichen Sie ANAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANAB
Anaptysbio Inc
|
24.77 | 770.36M | 17.16M | -163.62M | -121.61M | -6.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.61 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
546.43 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
390.39 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
671.94 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.81 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-12-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-04-16 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-03-12 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | BTIG Research | Buy |
| 2024-02-21 | Eingeleitet | Stifel | Buy |
| 2024-02-16 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-22 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-05-18 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-11-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-09-13 | Herabstufung | Truist | Buy → Hold |
| 2022-09-01 | Eingeleitet | Raymond James | Outperform |
| 2022-03-22 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-21 | Eingeleitet | UBS | Neutral |
| 2021-03-16 | Hochstufung | Truist | Hold → Buy |
| 2021-03-09 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-03-08 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2021-02-11 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2020-10-27 | Hochstufung | Wedbush | Neutral → Outperform |
| 2020-10-14 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-11-08 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2019-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-08 | Herabstufung | SunTrust | Buy → Hold |
| 2019-11-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-06-21 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-06-21 | Herabstufung | Stifel | Buy → Hold |
| 2018-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-11-21 | Eingeleitet | JP Morgan | Overweight |
| 2018-07-19 | Eingeleitet | Credit Suisse | Outperform |
| 2018-04-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-03-27 | Bestätigt | Stifel | Buy |
| 2018-03-06 | Bestätigt | Stifel | Buy |
| 2018-02-15 | Bestätigt | SunTrust | Buy |
| 2018-01-23 | Bestätigt | Credit Suisse | Outperform |
| 2017-11-15 | Eingeleitet | SunTrust | Buy |
| 2017-11-09 | Eingeleitet | Jefferies | Buy |
| 2017-10-11 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Anaptysbio Inc Aktie (ANAB) Neueste Nachrichten
How does AnaptysBio Inc. compare to its industry peersFinancial News Updates For Consistent Profits - jammulinksnews.com
What makes AnaptysBio Inc. stock price move sharplyFinancial News Data Feed With High Returns - jammulinksnews.com
Is it the right time to buy AnaptysBio Inc. stockDaily Trading Strategy For Smart Trading - jammulinksnews.com
Skandinaviska Enskilda Banken AB publ Takes $623,000 Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio Inc. Moves Into Bullish Territory Based on MACDValue Investing Picks With Stability Outlined - metal.it
Why is AnaptysBio Inc. stock attracting strong analyst attentionWealth Building Trend Scanner For Smart Trading - jammulinksnews.com
How does AnaptysBio Inc. generate profit in a changing economyEarnings Report Outlook For 2025 - jammulinksnews.com
What is the risk reward ratio of investing in AnaptysBio Inc. stockMarket Forecast Opportunities Backed By Experts - jammulinksnews.com
What are AnaptysBio Inc. company’s key revenue driversChart Pattern Updates With High Returns - jammulinksnews.com
AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Corton Capital Inc. Acquires Shares of 10,699 AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
What technical models suggest about AnaptysBio Inc.’s comebackAI Screener for Daily Stock Forecast - Newser
AnaptysBio (ANAB) Projected to Post Quarterly Earnings on Monday - MarketBeat
Is AnaptysBio Inc. stock overvalued or undervaluedBuild wealth faster with disciplined trading - jammulinksnews.com
Order flow analysis tools used on AnaptysBio Inc. Sector-Wise Stock Strength Trend Analysis - Newser
How many analysts rate AnaptysBio Inc. as a “Buy”Chart Pattern Planner That Work - jammulinksnews.com
AnaptysBio (NASDAQ:ANAB) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
When is AnaptysBio Inc. stock expected to show significant growthAchieve consistent double-digit growth rates - jammulinksnews.com
Published on: 2025-07-27 22:00:06 - jammulinksnews.com
Is AnaptysBio Inc. stock a growth or value playSolid Return Trade Selections - Newser
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Victory Capital Management Inc. - MarketBeat
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for AnaptysBio (NASDAQ:ANAB) Stock - Defense World
Is AnaptysBio Inc. a good long term investmentConsistently high yield - PrintWeekIndia
What drives AnaptysBio Inc. stock priceExceptional market performance - PrintWeekIndia
AnaptysBio Analyst Expectations: Bullish Sentiments, Increasing Price Targets - AInvest
Does AnaptysBio Inc. stock pay reliable dividendsOutstanding trading profits - jammulinksnews.com
Trading (ANAB) With Integrated Risk Controls - news.stocktradersdaily.com
AnaptysBio Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com
What analysts say about AnaptysBio Inc. stockHigh-yield portfolio picks - jammulinksnews.com
How AnaptysBio Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser
Finanzdaten der Anaptysbio Inc-Aktie (ANAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anaptysbio Inc-Aktie (ANAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RENTON HOLLINGS | Director |
Jul 02 '25 |
Sale |
23.57 |
20,925 |
493,191 |
4,965 |
3.38%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):